General Forum, page-666

Someone will no doubt ask these few questions but just in case:

What's the sales pipeline forecast look like for pulse next year? is it tied directly the the $8M of clinician pipeline we haven't had confined yet?

What's the plan for funding early next year? Get them to clearly step through Nasdax step by step (this is always brushed over, I want to know each step and the criteria spelled out)

Is pulse generating any outside interest in the business? (we heard with mobvoi of outside suitors asking to be part of partnerships, knocking on the door etc) Is that still happening?

In the half year there were two professors/ leading global specialists we were working with who wrote a paper saying basically "no company has got this right yet". Is there any update with where they stand with pulse and if they will endorse?

What's the global talk about central blood pressure a year later? to be successful, the average GP must accept there is now a better way than his/ her trusty tried and true 2 measurements. Is this gaining traction?

thanks all.